DWTX Dogwood Therapeutics, Inc.
Healthcare · Pharmaceutical Preparations · Market cap: $42.4M
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $120.5K | $0 |
| 2022-Q2 | $105.3K | $0 |
| 2022-Q3 | $0 | $0 |
| 2022-Q4 | $0 | $468 |
| 2023-Q1 | $0 | $0 |
| 2023-Q2 | $0 | $0 |
| 2023-Q3 | $51.2K | $0 |
| 2023-Q4 | $0 | $0 |
| 2024-Q1 | $0 | $0 |
| 2024-Q2 | $0 | $0 |
| 2024-Q3 | $0 | $0 |
| 2024-Q4 | $0 | $0 |
| 2025-Q1 | $0 | $0 |
| 2025-Q2 | $0 | $0 |
| 2025-Q3 | $0 | $0 |
| 2025-Q4 | $0 | $0 |
| 2026-Q1 | $0 | $0 |
| 2026-Q2 | $0 | $0 |
| 2026-Q3 | $0 | $0 |
| 2026-Q4 | $0 | $0 |
Bought$355.7K18 buy days
Sold$4681 sell day
Net insider flow+$355.3Knet buying · 5 years
Latest trade2023-08-21Pridgen William
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2023-08-21 | Buy | Pridgen William | Director | 15,335 | $1.30 | $19.9K | 1 |
| 2023-08-17 | Buy | Duncan Gregory Scott | CEO | 25,000 | $1.25 | $31.2K | 1 |
| 2022-12-08 | Sell | Whitley Richard James | Director | 1,800 | $0.26 | $468 | 1 |
| 2022-05-23 | Buy | Duncan Gregory Scott | CEO | 7,500 | $4.52 | $33.9K | 1 |
| 2022-05-23 | Buy | Walsh Angela | EVP / SVP | 2,000 | $4.58 | $9.2K | 1 |
| 2022-05-18 | Buy | Whitley Richard James | Director | 500 | $4.53 | $2.3K | 1 |
| 2022-05-18 | Buy | Pridgen William | Director | 241 | $4.50 | $1.1K | 1 |
| 2022-05-17 | Buy | Pridgen William | Director | 13,450 | $4.38 | $58.9K | 1 |
| 2022-03-29 | Buy | Pridgen William | Director | 600 | $4.94 | $3.0K | 1 |
| 2022-03-23 | Buy | Pridgen William | Director | 2,197 | $5.46 | $12.0K | 1 |
| 2022-01-27 | Buy | Pridgen William | Director | 4,180 | $5.98 | $25.0K | 1 |
| 2022-01-07 | Buy | De La Rosa Abel | Director | 4,000 | $5.90 | $23.6K | 1 |
| 2022-01-06 | Buy | Whitley Richard James | Director | 1,800 | $5.72 | $10.3K | 1 |
| 2022-01-04 | Buy | Keefer David R | Director | 5,000 | $5.80 | $29.0K | 1 |
| 2022-01-04 | Buy | Thomas John C | Director | 1,000 | $5.65 | $5.6K | 1 |
| 2022-01-03 | Buy | Pridgen William | Director | 2,215 | $5.43 | $12.0K | 1 |
| 2021-12-23 | Buy | Whitley Richard James | Director | 200 | $5.73 | $1.1K | 1 |
| 2021-12-21 | Buy | Pridgen William | Director | 8,827 | $5.66 | $50.0K | 1 |
| 2021-12-21 | Buy | Duncan Gregory Scott | CEO | 5,000 | $5.52 | $27.6K | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Pridgen William | Director | $181.9K | $0 | 2023-08-21 |
| Duncan Gregory Scott | CEO | $92.8K | $0 | 2023-08-17 |
| Keefer David R | Director | $29.0K | $0 | 2022-01-04 |
| De La Rosa Abel | Director | $23.6K | $0 | 2022-01-07 |
| Whitley Richard James | Director | $13.7K | $468 | 2022-12-08 |
| Walsh Angela | EVP / SVP | $9.2K | $0 | 2022-05-23 |
| Thomas John C | Director | $5.6K | $0 | 2022-01-04 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2022-05-17 → 2022-05-23 | 4 | $105.3K | 53 | +8.6% (+9.3% raw) | +49.0% (+61.1% raw) | -99.1% (-92.2% raw) | closed |
| 2021-12-21 → 2022-01-27 | 6 | $184.3K | 56 | +18.1% (+6.3% raw) | -7.9% (-14.9% raw) | -4.7% (-26.8% raw) | closed |
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.